Skip to main content

Asa's status, and the way forward

Yesterday Selam, my mother, and I took Asa to London for assessment by retinoblastoma specialists.  In due course I’ll describe the health workers we met there.  Our first impressions are that they’re brilliant people who wear their knowledge and expertise lightly.  Based on the examinations they carried out and on what they told us, we’re now in a much better position to understand the stage of the disease and the treatment that’s necessary.

The stage of the disease

The International Classification for Intraocular Retinoblatoma grades severity on a scale from A to E.  A represents the best outcome, where chances of preserving vision are very good, and E represents the worst, where the eye must be removed to prevent metastasis. 

Asa is a D in both eyes.  There are multiple tumours in each eye, and they are large.  One indication of their size is that, while ocular tumours are conventionally described in millimeters, those in Asa’s eyes were described to us in centimeters: The largest in the left eye is 1.9 x 1.3 cm, and that in the right eye is 1.3 x 0.5 cm. 

The tumour in his right eye, while smaller, is more disadvantageously positioned, already impinging on the crucial area between the fovea and the optic nerve, and interfering with Asa’s sight.  The long-term chances of saving vision are therefore greater for the left eye than the right.

The left eye, however, is far from well: there are seeds – tiny pieces of tumour – that have already split off into the vitreous area of the eye, and should these grow, they would likely cause blindness in the left eye too.

Retcam image of left eye.  The mass at the bottom is the largest tumour; the spots and clouds above are subsidiary tumours.

Had the disease in each eye been fractionally worse, the doctors would have recommended removal of Asa’s eyes.  We’re grateful that they did not.  And we’re grateful too that there’s no evidence of the cancer having spread outside the eye.

What treatment do they have for this?

For children with bilateral retinoblastoma (cancer in both eyes) the standard treatment is systemic chemotherapy to shrink the tumours, accompanied by more focused therapies to attack them once they have shrunk. 

The first round of treatments will begin next week, and last about 5 months.  This includes 6 cycles of chemo, each lasting 3 weeks.  After every 2 cycles, he’ll be evaluated, and lasers or cryo may be used to attack the tumours. 

During the chemo, Asa is going to be delicate: We’re going to have to take special care to protect him from infection and to preserve his appetite.  His blood counts will need close monitoring, and if they plunge very low he may need blood transfusion.

A team effort

To pull all this off, we’ve been offered the help of a large team, including 

-- community nurses who will visit Asa at home each week to check blood counts and change the dressings on the shunt that will be used to funnel drugs into him;

-- paediatricians at our local hospital, whom we can call upon to manage any infections that Asa picks up along the way;

-- oncologists and ophthalmologists in London. 

We’ll also be relying on Asa’s own resilience and adaptability.  On love and support from friends and family.  And on God.

With help from these sources we pray Asa will overcome the cancer and retain his sight. 

There’s a long road ahead.


  1. What a great news. This definitely raises my hopes up. i know that God is there to protect this little child from anything worse. It's a delight to know that there is a solution to a problem we first thought was unsolvable. May God be with Asa, mimiye and you. I am praying for you everyday and i will continue to do so. I love you all. Hope to hear more good news sometime soon.

  2. During our girls' nighttime feedings these next few months, we'll pray for strength, peace, and health for all of you. With love from Alabama

  3. Elizabeth Tolmach13 January 2012 at 00:22

    My thoughts and love are with you and Selam.


Post a Comment

Popular posts from this blog


Maybe it's all the to-and-fro'ing we've done on the trains between London and Birmingham for his eye exams, or maybe it's due to some kind of innate fascination with large moving things, but Asa loves trains.

I post these drawings of his partly to cheer myself up. It's been a pretty rough week, watching the US elect a con man as President.

Asa is an American citizen, and in 13 years time he'll be eligible to vote. I'm grateful that he's healthy, and that he stands an excellent chance of living a full life. But I worry about the world that he and his generation will inherit.

Let us pray for wisdom in our leaders, and for strength and resolve for those who resist them in the cause of the greater good.

Blind for a day

My mum likes to say that we learn about our bodies the way we learn about cars -- each time something goes wrong, you get acquainted with a new branch of mechanics.

As various treatments have been tried out on Asa, we've learned more and more about cancer and the eye.

The graph below summarises the treatments Asa's received these past 18 months.

Situations where retinoblastoma fails to respond to both primary and secondarychemo are rare, and even at one of the world's specialist treatment centres, a doctor might see such a case only once every few years.

 Support research on eye cancer here.
Right now we're in a place, therefore, where epidemiology and large trials have ceased to help much, and clinical judgment becomes very important.

As Dr Jenkinson -- the oncologist we met with in Birmingham -- said, "We're beyond the situation where there's a firm evidence base."

What's required then is very close attention to the details of the disease as it'…

Mixed results

Last Wednesday Asa was put to sleep and underwent an eye exam under anaesthetic. 
The first since the beginning of the new chemo, the exam showed that the drugs have had a "partial effect."

In Asa's left eye, the tumours responded well to the chemo. 
But in the right eye, there's been a slight increase in tumour activity.
And in the left eye there's a cataract developing.
A mixed bag
This was not what we'd hoped to hear.
We had reason to expect that the TVD (topotecan-vincristine-doxorubicin) combination would lead to shrinkage of the tumours in both eyes. 
And the appearance of a cataract -- a clouding of the lens -- at this stage is unusual: puzzling to the doctors as well as us.
While cataracts can be removed through surgery, cutting into the eye when there are active tumours inside is not advisable. So treatment for the cataract itself will have to wait until the tumours are stable.
The main risk in the near future is that the cataract may make it difficult to moni…